156 related articles for article (PubMed ID: 34076978)
1. Long noncoding RNA NEAT1 aggravates sorafenib-resistance in non-small cell lung cancer via regulating miRNA-335/c-Met.
Mu L; Zhao H; Yang Y; Song R
J BUON; 2021; 26(2):345-352. PubMed ID: 34076978
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
3. LncRNA NEAT1 induces autophagy through the miR-128-3p/ADAM28 axis to suppress apoptosis of nonsmall-cell lung cancer.
Xie Y; Zheng ZW; He HT; Chang ZB
Kaohsiung J Med Sci; 2022 Oct; 38(10):933-949. PubMed ID: 36054559
[TBL] [Abstract][Full Text] [Related]
4. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
5. LncRNA NEAT1 regulated cell proliferation, invasion, migration and apoptosis by targeting has-miR-376b-3p/SULF1 axis in non-small cell lung cancer.
Chen LM; Niu YD; Xiao M; Li XJ; Lin H
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4810-4821. PubMed ID: 32432744
[TBL] [Abstract][Full Text] [Related]
6. m6A-mediated lncRNA NEAT1 plays an oncogenic role in non-small cell lung cancer by upregulating the HMGA1 expression through binding miR-361-3p.
Qi L; Yin Y; Sun M
Genes Genomics; 2023 Dec; 45(12):1537-1547. PubMed ID: 37688756
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
8. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development.
Wu F; Mo Q; Wan X; Dan J; Hu H
J Cell Biochem; 2019 Mar; 120(3):2836-2846. PubMed ID: 29095526
[TBL] [Abstract][Full Text] [Related]
9. NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells.
Jiang P; Wu X; Wang X; Huang W; Feng Q
Oncotarget; 2016 Jul; 7(28):43337-43351. PubMed ID: 27270317
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NEAT1/miR-1224/KLF3 contributes to cell proliferation, apoptosis and invasion in lung cancer.
Yu PF; Wang Y; Lv W; Kou D; Hu HL; Guo SS; Zhao YJ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8403-8410. PubMed ID: 31646570
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
12. NEAT1 mediates paclitaxel-resistance of non-small cell of lung cancer through activation of Akt/mTOR signalling pathway.
Li B; Gu W; Zhu X
J Drug Target; 2019 Dec; 27(10):1061-1067. PubMed ID: 30782035
[TBL] [Abstract][Full Text] [Related]
13. Nuclear paraspeckle assembly transcript 1 promotes the podocyte injury via targeting miR-23b-3p/B-cell lymphoma-2 interacting protein 3 like axis.
Wang J; Luo J; Du L; Shu X; Guo C; Li T
Ren Fail; 2022 Dec; 44(1):1961-1975. PubMed ID: 36350669
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NEAT1 promotes lipopolysaccharide-induced injury in human tubule epithelial cells by regulating miR-93-5p/TXNIP axis.
Yang J; Wu L; Liu S; Hu X; Wang Q; Fang L
Med Microbiol Immunol; 2021 Jun; 210(2-3):121-132. PubMed ID: 33885954
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NEAT1 promotes autophagy via regulating miR-204/ATG3 and enhanced cell resistance to sorafenib in hepatocellular carcinoma.
Li X; Zhou Y; Yang L; Ma Y; Peng X; Yang S; Li H; Liu J
J Cell Physiol; 2020 Apr; 235(4):3402-3413. PubMed ID: 31549407
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway.
Xu L; Xu Y; Yang M; Li J; Xu F; Chen BL
BMC Pulm Med; 2020 Oct; 20(1):266. PubMed ID: 33059643
[TBL] [Abstract][Full Text] [Related]
17. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA DANCR functions as an oncogenic role in non-small lung cancer by regulating miR-214-5p/CIZ1 axis.
Chen YR; Wu YS; Wang WS; Zhang JS; Wu QG
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2539-2547. PubMed ID: 32196604
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p/MDM4 axis.
Wang D; Zhang S; Zhao M; Chen F
Cancer Med; 2020 Dec; 9(23):9138-9149. PubMed ID: 33146951
[TBL] [Abstract][Full Text] [Related]
20. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
Huang Q; Xing S; Peng A; Yu Z
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
